Episodes (Page 12)
✨
Strategies for securing biotech investment in a challenging market.
Alistair McDonald
Claire Riches
✨
In vivo CAR-T therapy is advancing autoimmune disease treatment.
Meredith Landry
Pete Robinson
✨
Olon's integrated, end-to-end ADC manufacturing capabilities.
Alessandro Agosti
Matthieu Culie
✨
Biopharma news roundup for the week ending Oct 17, 2025.
✨
Key biopharma news from the week ending Oct 17, 2025.
✨
FDA Commissioner's potential role in AstraZeneca's drug pricing deal.
✨
Exploring the future direction of European B2B pharmaceutical markets.
✨
Lupus drug development is undergoing a significant transformation.
Stacie Bell
✨
Essential Pharma's strategic priorities and growth plans.
✨
Biopharma financing shows renewed optimism; CAR-T indications expand.
✨
Biopharma financing is regaining optimism; CAR-T strains capacity.
✨
Cereno Scientific repurposes an epilepsy drug for rare cardiopulmonary diseases.
Sten Sorensen
✨
eClinical's major reset and its impact on clinical trials.
✨
Pfizer's US pricing deal, Japan's drug tariff policy debated.
✨
AESGP launched a platform showcasing European self-care initiatives.
Luis Rhodes Baiao
✨
Pfizer's US pricing deal, Japan's pharma tariffs, and direct-to-patient schemes.
✨
Discussing US government shutdown's impact on the FDA.
✨
Pfizer re-enters obesity treatment via Metsera acquisition.
✨
Pfizer acquires Metsera, re-entering obesity market.
✨
John Murphy discusses the US off-patent market.
John Murphy III